S
Seng-Jaw Soong
Researcher at University of Alabama at Birmingham
Publications - 119
Citations - 18982
Seng-Jaw Soong is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Survival rate & Melanoma. The author has an hindex of 61, co-authored 119 publications receiving 18281 citations. Previous affiliations of Seng-Jaw Soong include Memorial Sloan Kettering Cancer Center & University of Texas System.
Papers
More filters
Journal ArticleDOI
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch,Jeffrey E. Gershenwald,Seng-Jaw Soong,John F. Thompson,Michael B. Atkins,David R. Byrd,Antonio C. Buzaid,Alistair J. Cochran,Daniel G. Coit,Shouluan Ding,Alexander M.M. Eggermont,Keith T. Flaherty,Phyllis A. Gimotty,John M. Kirkwood,Kelly M. McMasters,Martin C. Mihm,Donald L. Morton,Merrick I. Ross,Arthur J. Sober,Vernon K. Sondak +19 more
TL;DR: Revised melanoma staging system has been made that reflect the improved understanding of this disease and will be formally incorporated into the seventh edition of the AJCC Cancer Staging Manual and implemented by early 2010.
Journal ArticleDOI
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial
David W. Kimberlin,Chin Yu Lin,Pablo J. Sánchez,Gail J. Demmler,Wayne M. Dankner,Mark Shelton,Richard F. Jacobs,Wendy Vaudry,Robert F. Pass,Jan Kiell,Seng-Jaw Soong,Richard J. Whitley +11 more
TL;DR: In this paper, the authors evaluated the efficacy and safety of ganciclovir therapy in neonates with congenital cytomegalovirus (CMV) disease and found that 20% of the infants had improved hearing or maintained normal hearing between baseline and 6 months versus 10% of 17 control patients.
Journal ArticleDOI
Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis
Richard J. Whitley,Charles A. Alford,Martin S. Hirsch,Robert T. Schooley,James P. Luby,Fred Y. Aoki,Daniel F. Hanley,Andre J. Nahmias,Seng-Jaw Soong +8 more
TL;DR: It is concluded that acyclovir is currently the treatment of choice for biopsy-proved herpes simplex encephalitis and patients under 30 years of age and with a Glasgow coma score above 10 had the best outcome with acy Clovir treatment.
Journal ArticleDOI
Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex Encephalitis
Richard J. Whitley,Seng-Jaw Soong,Raphael Dolin,George J. Galasso,Lawrence T. Ch'ien,Charles A. Alford +5 more
TL;DR: Adenine arabinoside (vidarabine) was used for treatment of Type 1 herpes simplex encephalitis in a placebo-controlled study as mentioned in this paper, which reduced mortality from 70 to 28 per cent (P = 0.03).
Journal ArticleDOI
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems.
Richard J. Whitley,Seng-Jaw Soong,Martin S. Hirsch,Adolf W. Karchmer,Raphael Dolin,George J. Galasso,June K. Dunnick,Charles A. Alford +7 more
TL;DR: Results suggest that outcome is improved with treatment; they provide more support for the use of brain biopsy to diagnose the infection and indicate a need for better therapy.